According to CNBC, shares of Wegovy-maker Novo Nordisk rose 6% after approval of a GLP-1 pill, signaling a strong positive price reaction to the regulatory catalyst, source: CNBC. CNBC did not provide additional details in the tweet or any direct implications for the crypto market, source: CNBC.